Skip to main content

Laboratory Corp of America Holdings(LH-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume

Latest News

Labcorp to Announce Third Quarter Financial Results on October 27, 2022
Business Wire - Tue Sep 27, 6:00AM CDT
Business Wire
Tue Sep 27, 6:00AM CDT
Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the third quarter of 2022 before the market opens on Thursday, Oct. 27, 2022. The company will host a conference call and webcast beginning at 9...
Labcorp to Speak at the Baird 2022 Global Healthcare Conference
Business Wire - Tue Sep 6, 5:59AM CDT
Business Wire
Tue Sep 6, 5:59AM CDT
Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the Baird 2022 Global Healthcare Conference on Tuesday, Sept. 13, at 9:05 a.m. ET.
Labcorp Acquires Clinical Outreach Laboratory Services From RWJBarnabas Health
Business Wire - Tue Aug 23, 3:30PM CDT
Business Wire
Tue Aug 23, 3:30PM CDT
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of RWJBarnabas Health’s outreach laboratory business and select related assets. RWJBarnabas Health is New Jersey’s largest academic...
BD, Labcorp Collaborate to Develop Flow Cytometry-Based Companion Diagnostics for Matching Patients with Treatments
PR Newswire - Tue Aug 9, 5:50AM CDT
PR Newswire
Tue Aug 9, 5:50AM CDT
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration agreement with...
Laboratory Corporation of America (LH) Q2 2022 Earnings Call Transcript
Motley Fool - Fri Jul 29, 5:00AM CDT
Motley Fool
Fri Jul 29, 5:00AM CDT
LH earnings call for the period ending June 30, 2022.
Labcorp Announces 2022 Second Quarter Results
Business Wire - Thu Jul 28, 6:00AM CDT
Business Wire
Thu Jul 28, 6:00AM CDT
Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the second quarter ended June 30, 2022, and updated full-year guidance.
Labcorp to Spin Off Clinical Development Business
Business Wire - Thu Jul 28, 5:59AM CDT
Business Wire
Thu Jul 28, 5:59AM CDT
Labcorp (NYSE: LH) (the “Company”), a leading global life sciences company, today announced that its Board of Directors has authorized the Company to pursue a spin-off of the Company’s wholly owned Clinical Development business to Labcorp...
Labcorp Earns Top Score on 2022 Disability Equality Index
Business Wire - Fri Jul 22, 8:51AM CDT
Business Wire
Fri Jul 22, 8:51AM CDT
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it scored 100, the highest score possible, on the 2022 Disability Equality Index® (DEI), a comprehensive benchmarking tool for measuring disability inclusion in...
New Labcorp Test Report Helps Identify Insect Stings and Improve Therapy Decisions to Combat Allergic Reactions
Business Wire - Tue Jul 19, 3:25PM CDT
Business Wire
Tue Jul 19, 3:25PM CDT
Nearly 10 million people in the United States have a history of systemic or anaphylactic reaction to insect stings, with the risk of a severe and potentially life-threatening allergic reaction. To help facilitate more effective venom therapy, ...
Labcorp Expands Automated Clinical Trial Kit Production Line at European Operations Center
Business Wire - Mon Jul 18, 3:30PM CDT
Business Wire
Mon Jul 18, 3:30PM CDT
Labcorp ® (NYSE: LH), a leading global life sciences company, today announced an expansion of its automated clinical trial kit production line in Mechelen, Belgium. Once completed, expansion will allow for clinical trial test kits to be fulfilled...